Recently, a tissue microarray analysis showed that adding chromogranin to synaptophysin detects an extra 4.2% of breast cancer cases with neuroendocrine differentiation, while INSM1 identifies 15% of cases negative for both (22). The gene discussed is INSM1; the disease is breast carcinoma.